| 摘要 |
<p>The use of at least one β-adrenergic agonist as a P substance antagonist in a cosmetic composition or for preparing a pharmaceutical and particularly dermatological composition for treating disorders related to excessive P substance synthesis and/or release, is disclosed. A topical cosmetic or pharmaceutical composition including at least one β-adrenergic agonist, and a cosmetic treatment method for controlling pain caused by excessive P substance synthesis and/or release, or reducing the irritancy of a cosmetic composition, are also disclosed.</p> |
